Navigation Links
Genesis Biopharma Director William H. Andrews, Ph.D., Profiled in Popular Science Feature Story
Date:7/15/2011

LOS ANGELES, July 15, 2011 /PRNewswire/ -- The current issue of Popular Science magazine includes a feature story profiling William H. Andrews, a member of the Genesis Biopharma, Inc. (OTC/BB: GNBP) Board of Directors, and his work on the anti-aging properties of the human telomerase gene.

The entire 11-page story, titled "The Man Who Would Stop Time" by Joseph Hooper, can be found at www.popsci.com

About Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is a development-stage biotechnology company engaged in the development of targeted cancer therapies. For more information about the company, visit www.genesis-biopharma.com.


'/>"/>
SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Laszlo Radvanyi, Ph.D. Joins Genesis Biopharma Scientific and Medical Advisory Board
2. Genesis Biopharma Conference Call and Webcast Reminder
3. Genesis Biosciences Receives Pulire Innovation Award for e card Sanitary Bin Treatment Product
4. Patrick Hwu, M.D., and Mario Sznol, M.D., Join Genesis Biopharmas Scientific and Medical Advisory Board
5. Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board
6. ThermoGenesis Announces China Customer Implements Cord Blood Products
7. Tissue Genesis Begins FDA-Approved Clinical Trial
8. CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation
9. Organogenesis, Life Sciences Center Break Ground on Worlds Largest Automated Living Cell Manufacturing Plant
10. Announcing ValGenesis On-Demand SaaS Solution
11. Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... MA and Azusa, CA (PRWEB) , ... December ... ... provider of distributed wastewater treatment and resource recovery solutions for industrial facilities, today ... Company , will be the first to use Cambrian’s novel water-energy purchase agreement ...
(Date:12/7/2016)... , ... December 07, 2016 ... ... opening applications to an early access program for SmartBiome -- a novel ... with the simultaneous specific enrichment and detection of hundreds of different genes. ...
(Date:12/6/2016)... 2016 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... quarter and fiscal year ended September 30, 2016. ... , , ... and diagnostics company that develops and commercializes proprietary technologies and products ... Achieved revenues of $1.4 million more than tripling prior years ...
(Date:12/6/2016)... ... 06, 2016 , ... Discovering new clues to natural treatments that could allow ... in our brains. And searching for keys to our immune systems by studying parasite-resistant ... the 2017 Edith and Peter O’Donnell Awards by The Academy of ...
Breaking Biology Technology:
(Date:11/19/2016)... 18, 2016 Securus Technologies, a leading provider ... safety, investigation, corrections and monitoring, announced today that it ... to have an independent technology judge determine who has ... high tech/sophisticated telephone calling platform, and the best customer ... do most of what we do – which clearly ...
(Date:11/17/2016)... , Nov. 17, 2016  AIC announces that it has just released a new ... that require high-performance scale-out plus high speed data transfer storage solutions. Photo ... ... ... Setting up a high performance computing ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
Breaking Biology News(10 mins):